
Long-term canakinumab data in FMF from RELIANCE registry. 63% in remission at month 24. @RheumNow #EULAR2022 OP0042 https://t.co/mEIoAszmZq https://t.co/IvR1cSG4Aq
Links:
EULAR Abstract Archive
http://scientific.sparx-ip.net/archiveeular/index.cfm?c=a&searchfor=op0042&view…
01-06-2022